189 related articles for article (PubMed ID: 30178598)
21. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.
Egerman MA; Cadena SM; Gilbert JA; Meyer A; Nelson HN; Swalley SE; Mallozzi C; Jacobi C; Jennings LL; Clay I; Laurent G; Ma S; Brachat S; Lach-Trifilieff E; Shavlakadze T; Trendelenburg AU; Brack AS; Glass DJ
Cell Metab; 2015 Jul; 22(1):164-74. PubMed ID: 26001423
[TBL] [Abstract][Full Text] [Related]
22. Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.
Vamvini MT; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Nov; 96(11):3416-23. PubMed ID: 21865351
[TBL] [Abstract][Full Text] [Related]
23. Activin type II receptor signaling in cardiac aging and heart failure.
Roh JD; Hobson R; Chaudhari V; Quintero P; Yeri A; Benson M; Xiao C; Zlotoff D; Bezzerides V; Houstis N; Platt C; Damilano F; Lindman BR; Elmariah S; Biersmith M; Lee SJ; Seidman CE; Seidman JG; Gerszten RE; Lach-Trifilieff E; Glass DJ; Rosenzweig A
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842316
[TBL] [Abstract][Full Text] [Related]
24. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.
Bowser M; Herberg S; Arounleut P; Shi X; Fulzele S; Hill WD; Isales CM; Hamrick MW
Exp Gerontol; 2013 Feb; 48(2):290-7. PubMed ID: 23178301
[TBL] [Abstract][Full Text] [Related]
25. Personalized risk assessment of heart failure patients: more perspectives from transforming growth factor super-family members.
Goletti S; Gruson D
Clin Chim Acta; 2015 Mar; 443():94-9. PubMed ID: 25260834
[TBL] [Abstract][Full Text] [Related]
26. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
27. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
[TBL] [Abstract][Full Text] [Related]
28. Effects of elastic band resistance training and nutritional supplementation on muscle quality and circulating muscle growth and degradation factors of institutionalized elderly women: the Vienna Active Ageing Study (VAAS).
Hofmann M; Schober-Halper B; Oesen S; Franzke B; Tschan H; Bachl N; Strasser EM; Quittan M; Wagner KH; Wessner B
Eur J Appl Physiol; 2016 May; 116(5):885-97. PubMed ID: 26931422
[TBL] [Abstract][Full Text] [Related]
29. Differing Effects of Younger and Older Human Plasma on C2C12 Myocytes
Kalampouka I; van Bekhoven A; Elliott BT
Front Physiol; 2018; 9():152. PubMed ID: 29535644
[TBL] [Abstract][Full Text] [Related]
30. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.
Zimmers TA; Jiang Y; Wang M; Liang TW; Rupert JE; Au ED; Marino FE; Couch ME; Koniaris LG
Basic Res Cardiol; 2017 Jul; 112(4):48. PubMed ID: 28647906
[TBL] [Abstract][Full Text] [Related]
31. Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes.
Añón-Hidalgo J; Catalán V; Rodríguez A; Ramírez B; Silva C; Galofré JC; Salvador J; Frühbeck G; Gómez-Ambrosi J
Aging (Albany NY); 2019 Mar; 11(6):1733-1744. PubMed ID: 30897065
[TBL] [Abstract][Full Text] [Related]
32. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for potency differences between GDF8 and GDF11.
Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB
BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634
[TBL] [Abstract][Full Text] [Related]
34. Effects of Soy Milk in Conjunction With Resistance Training on Physical Performance and Skeletal Muscle Regulatory Markers in Older Men.
Bijeh N; Mohammadnia-Ahmadi M; Hooshamnd-Moghadam B; Eskandari M; Golestani F
Biol Res Nurs; 2022 Jul; 24(3):294-307. PubMed ID: 35332795
[No Abstract] [Full Text] [Related]
35. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
[TBL] [Abstract][Full Text] [Related]
36. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.
Vernerová L; Horváthová V; Kropáčková T; Vokurková M; Klein M; Tomčík M; Oreská S; Špiritović M; Štorkánová H; Heřmánková B; Kubínová K; Kryštůfková O; Mann H; Ukropec J; Ukropcová B; Vencovský J
Rheumatology (Oxford); 2020 Sep; 59(9):2491-2501. PubMed ID: 31990347
[TBL] [Abstract][Full Text] [Related]
37. Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study.
Moriwaki K; Matsumoto H; Tanishima S; Tanimura C; Osaki M; Nagashima H; Hagino H
BMC Musculoskelet Disord; 2019 Jun; 20(1):276. PubMed ID: 31164134
[TBL] [Abstract][Full Text] [Related]
38. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans.
Vamvini MT; Aronis KN; Panagiotou G; Huh JY; Chamberland JP; Brinkoetter MT; Petrou M; Christophi CA; Kales SN; Christiani DC; Mantzoros CS
Eur J Endocrinol; 2013 Dec; 169(6):829-34. PubMed ID: 24062354
[TBL] [Abstract][Full Text] [Related]
39. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.
Sinha M; Jang YC; Oh J; Khong D; Wu EY; Manohar R; Miller C; Regalado SG; Loffredo FS; Pancoast JR; Hirshman MF; Lebowitz J; Shadrach JL; Cerletti M; Kim MJ; Serwold T; Goodyear LJ; Rosner B; Lee RT; Wagers AJ
Science; 2014 May; 344(6184):649-52. PubMed ID: 24797481
[TBL] [Abstract][Full Text] [Related]
40. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
Fan X; Gaur U; Sun L; Yang D; Yang M
Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
